2022
DOI: 10.3389/fgene.2022.938183
|View full text |Cite
|
Sign up to set email alerts
|

Potentials and challenges of chromosomal microarray analysis in prenatal diagnosis

Abstract: Introduction: For decades, conventional karyotyping analysis has been the gold standard for detecting chromosomal abnormalities during prenatal diagnosis. With the development of molecular cytogenetic methods, this situation has dramatically changed. Chromosomal microarray analysis (CMA), a method of genome-wide detection with high resolution, has been recommended as a first-tier test for prenatal diagnosis, especially for fetuses with structural abnormalities.Methods: Based on the primary literature, this rev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
11
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 43 publications
(69 reference statements)
0
11
0
2
Order By: Relevance
“…Karyotype and CMA analysis are two prenatal diagnostic methods that have been widely used in recent years [15][16][17] . As molecular cytogenetic methods have advanced, Chromosomal Microarray Analysis (CMA) has gained prominence and is now suggested as a primary diagnostic test for prenatal assessments.The potential of CMA and the challenges, when compared to conventional karyotyping, are discussed below [3] .However, CMA cannot detect balanced translocations and inverted mosaicism. Karyotype analyses and SNP-arrays have their own advantages and limitations for the diagnosis of mosaicisms and the combination of these methods provides a rigorous diagnosis [15,16] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Karyotype and CMA analysis are two prenatal diagnostic methods that have been widely used in recent years [15][16][17] . As molecular cytogenetic methods have advanced, Chromosomal Microarray Analysis (CMA) has gained prominence and is now suggested as a primary diagnostic test for prenatal assessments.The potential of CMA and the challenges, when compared to conventional karyotyping, are discussed below [3] .However, CMA cannot detect balanced translocations and inverted mosaicism. Karyotype analyses and SNP-arrays have their own advantages and limitations for the diagnosis of mosaicisms and the combination of these methods provides a rigorous diagnosis [15,16] .…”
Section: Discussionmentioning
confidence: 99%
“…CMA is a genomic hybridization method that is superior to karyotype analysis, but CMA is unable to detect balanced recombinations and is more expensive [2] . However, pregnant women may also bene t from CMA method, which enables the simultaneous detection of copy number variations, ROH and SNPs [3] . Uniparental disomy (UPD) refers to the inheritance of both homologous chromosomes within a chromosome pair from a single parent.…”
mentioning
confidence: 99%
“…CMA is a high-resolution method for genome-wide detection and is recommended as the primary test for prenatal diagnosis [18,19]. This method can be used to detect the CNVs of chromosomal imbalances such as aneuploidy and unbalanced rearrangements, particularly chromosome microdeletions and duplications [12]. With a normal karyotype, CMA can detect approximately 1% clinically signi cant microdeletions/microduplications in structurally normal pregnancies and 6% structural anomalies in prenatal diagnostic cases [20].…”
Section: Discussionmentioning
confidence: 99%
“…Chromosomal microarray analysis (CMA) is used to detect CNVs in the whole genome. This method can be used to detect CNVs of chromosome imbalances, such as aneuploidy and unbalanced rearrangements, particularly chromosome microdeletions and duplications that cannot be detected using standard karyotyping [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…CMA is a genomic hybridization method that is superior to karyotype analysis, but it cannot detect balanced recombination and is more expensive [ 22 ]. However, pregnant women may also benefit from CMA method, which enables the simultaneous detection of copy number variations, ROH and SNPs [ 19 ]. There are three scenarios in which ROH appears in the prenatal sample: (a) Indication of UPD: when a ROH of > 10 Mb occurred on a single chromosome of a fetus (at the end of the chromosome, ROH > 5 Mb,not at the end of the chromosome, ROH > 10 Mb), (b) Identity of descent: ROH > 10 Mb appears on multiple chromosomes, indicating a close parental relationship (the closer the relationship, the more ROH regions), (c) Common ancestral markers in populations.…”
Section: Introductionmentioning
confidence: 99%